Eight global HTA (health technology assessment) organizations were compared in a recent study. The leaders were NICE (UK), ICER (US), and TLV (Sweden). Only these three institutions “were closest to achieving the dual aim of improved sustainability and patient centricity.” In response to feedback from payers, pharma companies, and patients, ICER made changes to its value assessment.
Joshua Cohen of Forbes notes “We analyzed the ability of eight value frameworks operated by HTAs, medical professional societies, hospitals, and patient advocacy groups, to achieve the dual aim of sustainable healthcare funding and incorporation of patient-centered preferences and outcomes.” Read the study here.
(Sources: Joshua Cohen, Forbes, 1/30/21 & ICER 1/31/20)
